financetom
Business
financetom
/
Business
/
Greece to set up its first sovereign wealth fund, reform posting, bus services
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Greece to set up its first sovereign wealth fund, reform posting, bus services
Jun 18, 2024 8:35 AM

ATHENS, June 18 (Reuters) - Greece will set up its first

sovereign wealth fund to sell state assets such as estate

property, ports and public utilities that were not sold during

its debt crisis, its finance minister said on Tuesday.

The fund, with initial capital of 300 million euros, will

invest proceeds from thousands of state asset sales into green

projects, infrastructure and new technology, Finance Minister

Kostis Hatzidakis said in a news conference, unveiling the plan.

"We hired BlackRock ( BLK ) to propose the best corporate structure

for the fund," he added.

Greece's privatisation agency HRADF and its bank bailout

fund HFSF will be absorbed by the Hellenic Corporation of Assets

and Participations (HCAP), which manages a portfolio of state

utilities and participations.

The funds jointly raised more than 10 billion euros from the

sale of state assets and bank stakes to help Greece cut its debt

during its 2010-2018 crisis, Hatzidakis said.

HFSF, which recently fully privatised three Greek lenders,

plans to sell its remaining 18% stake in National Bank

and a 72.5% in Attica Bank by the end of the year, Hatzidakis

said.

Greece will also look to modernise its bus and postal

services by allowing their state operators hire workers from the

private sector and offer them pay flexibility.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Mar 16, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
CytomX Therapeutics Details Phase 1 Trial Results For Colorectal Cancer Treatment
CytomX Therapeutics Details Phase 1 Trial Results For Colorectal Cancer Treatment
Mar 16, 2026
08:12 AM EDT, 03/16/2026 (MT Newswires) -- CytomX Therapeutics ( CTMX ) said Monday a Phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%. Patients receiving the 10-milligram per kilogram dose demonstrated an estimated median progression-free survival of 7.1 months, the company said. The 8.6-milligram per kilogram cohort...
Monte Rosa Therapeutics Signs Supply Deal With Johnson & Johnson for Phase 2 Prostate Cancer Study
Monte Rosa Therapeutics Signs Supply Deal With Johnson & Johnson for Phase 2 Prostate Cancer Study
Mar 16, 2026
08:13 AM EDT, 03/16/2026 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said Monday it has entered a clinical supply agreement with Johnson & Johnson ( JNJ ) to evaluate investigational drug MRT-2359 in combination with Erleada in patients with metastatic castration-resistant prostate cancer with androgen receptor mutations. Under the agreement, Monte Rosa Therapeutics ( GLUE ) will sponsor...
Form 8.3
Form 8.3
Mar 16, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved